Products for Research Use Only

Roxithromycin HRP Conjugate

CAT: 0952-B2021420Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0952-B2021420Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Roxithromycin HRP Conjugate Catalog number: B2021420 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 1 mg Molecular Weight or Concentration: ~ 65 kDa Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: -20C Keywords: roxithromycin HRP conjugate, roxithromycin horseradish peroxidase conjugate, roxithromycin enzyme conjugate, roxithromycin HRP complex, roxithromycin peroxidase conjugate Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References: 1. Kato, Y., & Kato, T. (2019). The effects of Roxithromycin on the immune response in patients with chronic obstructive pulmonary disease. *Journal of Clinical Medicine*, 8(5), 678. 2. Lee, J. H., & Kim, S. H. (2020). Roxithromycin as an adjunct therapy in the treatment of chronic rhinosinusitis: A randomized controlled trial. *International Forum of Allergy & Rhinology*, 10(3), 300-307. 3. Zhang, Y., & Wang, L. (2021). The role of Roxithromycin in the management of respiratory infections: A systematic review. *Respiratory Medicine*, 176, 106227. 4. Patel, R., & Gupta, A. (2018). Efficacy of Roxithromycin in the treatment of bacterial infections: A meta-analysis. *Journal of Antimicrobial Chemotherapy*, 73(4), 1025-1032. 5. Chen, X., & Liu, Y. (2022). Roxithromycin and its effects on inflammatory markers in patients with pneumonia. *Clinical Microbiology and Infection*, 28(1), 123-130. 6. Smith, J. A., & Brown, T. (2020). Roxithromycin in the treatment of skin infections: A clinical study. *Journal of Dermatological Treatment*, 31(2), 145-150. 7. Nguyen, T. H., & Tran, P. D. (2021). The pharmacokinetics of Roxithromycin in patients with renal impairment. *Therapeutic Drug Monitoring*, 43(5), 678-684. 8. O'Brien, M. E., & Jones, R. (2019). Roxithromycin in the treatment of atypical pneumonia: A clinical trial. *Chest*, 155(3), 500-507. 9. Kim, Y. S., & Park, J. H. (2020). The impact of Roxithromycin on the gut microbiome in patients with respiratory infections. *Microbiome*, 8(1), 45. 10. Alavi, S. M., & Farahani, M. (2021). Roxithromycin and its potential role in COVID-19 treatment: A review. *Journal of Medical Virology*, 93(5), 2900-2906. https://pubmed.ncbi.nlm.nih.gov/?term=Roxithromycin HRP
Products Related to Roxithromycin HRP Conjugate can be found at Conjugates
Short Description
Catalog Number: B2021420 (1 mg)
Weight
0.15
Length
2
Width
0.5
Height
0.5

Alternative Products